Literature DB >> 19709349

Expression and role of metalloproteinase-2 and endogenous tissue regulator in ameloblastoma.

Bin Zhang1, Jin Zhang, Hong-Zhang Huang, Zhi-Ying Xu, Hong-Liang Xie.   

Abstract

BACKGROUND: Ameloblastoma is a frequently encountered odontogenic benign tumor characterized by local invasiveness and high risk of recurrence. Matrix metalloproteinase (MMP)-2 can degrade type IV collagen, one of the major components in the basement membrane, resulting in the promotion of tumor invasion, whereas it is under the influence of an activator, membrane type 1-MMP-14 and the tissue inhibitor of metalloproteases (TIMP)-2. The aim of this study was to investigate combinatorial role played by MMP-2, TIMP-2 and MMP-14 in ameloblastoma.
METHODS: Transcriptional expression of MMP-2, TIMP-2 and MMP-14 in tissue extracts of 42 ameloblastomas and 10 dental follicles was detected using reverse transcription-polymerase chain reaction, and compared difference in clinical type and local recurrence of ameloblastoma.
RESULTS: MMP-2, TIMP-2 and MMP-14 mRNA were detected in all investigated ameloblastoma tissues. While MMP-2 mRNA was only expressed in eight of 10 odontotheca tissues and TIMP- 2 and MMP-14 were not found in all odontotheca tissues. The mRNA expression of MMP-2, TIMP-2 and MMP-14 were significantly higher in ameloblastoma tissues than in odontotheca tissues. The mRNA levels of TIMP-2 and MMP-14 were significantly higher in recurrent and solid/multicystic ameloblastoma tissues than in primary and unicystic ameloblastoma tissues respectively.
CONCLUSIONS: Of the MMP-2/TIMP-2/MMP-14 complex, a high expression of MMP-2, TIMP-2 and MMP-14 mRNA levels may contribute to the local invasive characteristics of ameloblastoma, whereas the local invasive capacity of ameloblastoma is more likely related to a high transcriptional levels of TIMP-2 and MMP-14.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19709349     DOI: 10.1111/j.1600-0714.2009.00827.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  6 in total

1.  Fibroblasts promote the collective invasion of ameloblastoma tumor cells in a 3D coculture model.

Authors:  Takao Fuchigami; Hirofumi Koyama; Michiko Kishida; Yoshiaki Nishizawa; Mikio Iijima; Toshiro Kibe; Masahiro Ueda; Tohru Kiyono; Yoshimasa Maniwa; Norifumi Nakamura; Shosei Kishida
Journal:  FEBS Open Bio       Date:  2017-11-02       Impact factor: 2.693

2.  Bioinformatics Analysis Reveals Genes Involved in the Pathogenesis of Ameloblastoma and Keratocystic Odontogenic Tumor.

Authors:  Eliane Macedo Sobrinho Santos; Hércules Otacílio Santos; Ivoneth Dos Santos Dias; Sérgio Henrique Santos; Alfredo Maurício Batista de Paula; John David Feltenberger; André Luiz Sena Guimarães; Lucyana Conceição Farias
Journal:  Int J Mol Cell Med       Date:  2016-12-06

3.  Intercellular signaling between ameloblastoma and osteoblasts.

Authors:  Elissa Chairani; Takao Fuchigami; Hirofumi Koyama; Yusuke Ono; Mikio Iijima; Michiko Kishida; Toshiro Kibe; Norifumi Nakamura; Shosei Kishida
Journal:  Biochem Biophys Rep       Date:  2022-02-18

4.  Epigenetic regulation of matrix metalloproteinase expression in ameloblastoma.

Authors:  Lucyana Conceição Farias; Carolina Cavaliéri Gomes; Marcela Carolina Rodrigues; Wagner Henriques de Castro; Júlio César Tanos Lacerda; Efigênia Ferreira E Ferreira; Ricardo Santiago Gomez
Journal:  BMC Clin Pathol       Date:  2012-08-06

5.  Molecular markers of tumor invasiveness in ameloblastoma: An update.

Authors:  Yi Zhong; Wei Guo; Li Wang; Xinming Chen
Journal:  Ann Maxillofac Surg       Date:  2011-07

6.  Portulacerebroside A inhibits adhesion, migration, and invasion of human leukemia HL60 cells and U937 cells through the regulation of p38/JNK signaling pathway.

Authors:  Qidong Ye; Xuelian Liao; Pan Fu; Jiaying Dou; Kai Chen; Hui Jiang
Journal:  Onco Targets Ther       Date:  2016-11-11       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.